IFG Advisory’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-4,864
Closed -$314K 489
2021
Q1
$314K Buy
4,864
+1,064
+28% +$68.6K 0.04% 385
2020
Q4
$221K Buy
3,800
+353
+10% +$21.3K 0.03% 421
2020
Q3
$217K Sell
3,447
-48
-1% -$3.33K 0.04% 377
2020
Q2
$268K Buy
3,495
+37
+1% +$2.84K 0.05% 324
2020
Q1
$258K Sell
3,458
-242
-7% -$16.7K 0.06% 297
2019
Q4
$240K Sell
3,700
-477
-11% -$31.1K 0.04% 360
2019
Q3
$264K Sell
4,177
-819
-16% -$53.5K 0.05% 331
2019
Q2
$337K Buy
4,996
+281
+6% +$18.5K 0.06% 257
2019
Q1
$306K Sell
4,715
-1,161
-20% -$77.2K 0.06% 264
2018
Q4
$367K Sell
5,876
-4,600
-44% -$322K 0.09% 220
2018
Q3
$808K Sell
10,476
-2,454
-19% -$185K 0.15% 140
2018
Q2
$915K Sell
12,930
-753
-6% -$53.2K 0.19% 122
2018
Q1
$1.03M Sell
13,683
-1,210
-8% -$96.2K 0.23% 101
2017
Q4
$1.07M Buy
+14,893
New +$1.13M 0.24% 96

Other funds holding GILD

IFG Advisory's GILD Position: Q2 2021 in Review

IFG Advisory sold out of Gilead Sciences (GILD) in Q2 2021, closing a stake of 4,864 shares — an estimated $314K sold.

IFG Advisory first reported a position in GILD in Q4 2017 and held it in 14 quarters. The position peaked at $1.07M in Q4 2017. 1,544 funds tracked by Wall St. Rank hold GILD as of Q2 2021.

  • IFG Advisory reported no remaining Gilead Sciences position as of Q2 2021 after selling out during the quarter.
  • IFG Advisory sold 4,864 Gilead Sciences shares in Q2 2021, an estimated $314K.
  • IFG Advisory first reported a position in Gilead Sciences in Q4 2017 and held it in 14 quarters.
  • IFG Advisory's Gilead Sciences position peaked at $1.07M in Q4 2017.
  • 1,544 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.

Based on IFG Advisory's 13F filing for Q2 2021, filed 21 Jul 2021.